Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC01398 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PREX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLUH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNF4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RY13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRMPD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on